Skip to main content
Equibles

UBS Group AG

Position in MAIA — MAIA Biotechnology, Inc.

CIK 1610520 ZURICH, V8
Back to MAIA Full portfolio

Position in MAIA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$48,145
-$24,538 QoQ
Shares Held
33,435
-35.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 36 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. MAIA ranks #396 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in MAIA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,145 33,435
2026-03-31 $72,683 51,917
2025-12-31 $3,319 2,170
2025-06-30 $3,816 2,120
2025-03-31 $459 300
2024-09-30 $46,884 16,685
2023-12-31 $1,167 998
2023-09-30 $292 133
2023-03-31 $13,663 3,949
2022-12-31 $10,635 3,030
2022-09-30 $15,140 4,588